Skip to content


The chemotherapy drugs Gemcitabine and Dacarbazine, when used in combination, constitute a chemotherapy regimen for treating Advanced Soft Tissue Sarcomas. Understanding the intricacies of this treatment, including its administration, potential side effects, and precautionary measures, is essential for patients to actively engage in their care and enhance treatment outcomes.